Skip to contentG
Greenwich LifeSciences, Inc.
G
GLSIGreenwich LifeSciences, Inc. Released Aug 21, 2023, after the close
10-Q filed Aug 21, 2023, 52 days after period end · 0001493152-23-029605
Q2 2023 · 10-Q
Revenue—
Net Income-$1.63M-$1.63MN/M vs Q2 2022N/M vs Q1 2023 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
-$0.13-$0.13N/M vs Q2 2022N/M vs Q1 2023 Operating Income-$1,747,826N/M Operating Cash Flowderived-$966,977N/M Filing lag
ended Jun 30, 2023 · filed Aug 21, 2023 · 52 d after period end